Financhill
Back

Amedisys 10K Form

Buy
55

AMED
Amedisys

Last Price:
92.15
Seasonality Move:
5.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AMED News And Ratings

See the #1 stock for the next 7 days that we like better than AMED

AMED Financial Statistics

Sales & Book Value

Annual Sales: $2.24B
Cash Flow: $58.21M
Price / Cash Flow: 24.27
Annual Sales: $32.65
Price / Book: 2.83

Profitability

EPS (TTM): -0.31000
Net Income (TTM): $-9.75M
Gross Margin: $990.87M
Return on Equity: -0.88%
Return on Assets: -0.49%

Amedisys Earnings Forecast

Key Amedisys Financial Ratios

  • The Gross Profit Margin over the past 31 years for AMED is 44.31%.
  • The Selling, General & Administrative Expenses for AMED have been equal to 34.88% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -320.86% of Operating Income.
  • The Net Earning history of AMED is -0.44% of Total Revenues.
  • Per Share Earnings over the last 31 years have been positive in 17 years.

Amedisys Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Care Facilities
Sector: Healthcare
Current Symbol: AMED
CUSIP: 023436
Website: amedisys.com

Debt

Debt-to-Equity Ratio: 0.37
Current Ratio: 1.05
Quick Ratio: 0.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 18.42

AMED Technical Analysis vs Fundamental Analysis

Buy
55
Amedisys (AMED) is a Buy

Is Amedisys a Buy or a Sell?

  • Amedisys stock is rated a Buy
    The current Amedisys [AMED] share price is $92.48. The Score for AMED is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.